Publication Date
| In 2026 | 0 |
| Since 2025 | 0 |
| Since 2022 (last 5 years) | 0 |
| Since 2017 (last 10 years) | 0 |
| Since 2007 (last 20 years) | 2 |
Descriptor
| Check Lists | 2 |
| Children | 2 |
| Scores | 2 |
| Aggression | 1 |
| Autism | 1 |
| Behavior Disorders | 1 |
| Behavior Problems | 1 |
| Correlation | 1 |
| Developmental Disabilities | 1 |
| Drug Therapy | 1 |
| Error of Measurement | 1 |
| More ▼ | |
Author
| Aman, Michael G. | 1 |
| Danov, Stacy E. | 1 |
| Kaat, Aaron J. | 1 |
| Lecavalier, Luc | 1 |
| Meyers, Stephanie | 1 |
| Symons, Frank J. | 1 |
| Tervo, Raymond | 1 |
Publication Type
| Journal Articles | 2 |
| Reports - Research | 2 |
Education Level
Audience
Location
Laws, Policies, & Programs
Assessments and Surveys
| Aberrant Behavior Checklist | 2 |
| Child Behavior Checklist | 2 |
What Works Clearinghouse Rating
Kaat, Aaron J.; Lecavalier, Luc; Aman, Michael G. – Journal of Autism and Developmental Disorders, 2014
The Aberrant Behavior Checklist (ABC) is a widely used measure in autism spectrum disorder (ASD) treatment studies. We conducted confirmatory and exploratory factor analyses of the ABC in 1,893 children evaluated as part of the Autism Treatment Network. The root mean square error of approximation was .086 for the standard item assignment, and in…
Descriptors: Validity, Children, Autism, Pervasive Developmental Disorders
Danov, Stacy E.; Tervo, Raymond; Meyers, Stephanie; Symons, Frank J. – Journal of Mental Health Research in Intellectual Disabilities, 2012
The atypical antipsychotic medication aripiprazole was evaluated using a randomized AB multiple baseline, double-blind, placebo-controlled design for the treatment of severe problem behavior with 4 children with intellectual and developmental disabilities. Functional analysis (FA) was conducted concurrent with the medication evaluation to…
Descriptors: Developmental Disabilities, Rating Scales, Reinforcement, Drug Therapy

Peer reviewed
Direct link
